Inventor · disambiguated record
Sung Youb Jung
Also filed as: JUNG SUNG YOUB
66 granted patents·24 pending applications·457 citations·filing 1994–2022
99Inventor score
Files withHANMI PHARM IND CO LTD54HANMI SCIENCE CO LTD12JUNG SUNG YOUB6HANMI PHARMACEUTICAL CO LTD3HANML PHARM CO LTD3
Top patents by PatentIndex Score
90 records- 0198US10370426B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Aug 6, 2019·21 cites·16 claims
- 0296US8263084B2Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugateSONG DAE HAE·Filed 2008·Granted Sep 11, 2012·37 cites·6 claims
- 0396US7736653B2Pharmaceutical composition comprising an immunoglobulin Fc region as a carrierHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·80 cites·13 claims
- 0495US9731031B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofJUNG SUNG YOUB·Filed 2012·Granted Aug 15, 2017·16 cites·78 claims
- 0595US8110665B2Pharmaceutical composition comprising an immunoglobulin FC region as a carrierKIM YOUNG MIN·Filed 2010·Granted Feb 7, 2012·24 cites·11 claims
- 0693US10918736B2Conjugate of therapeutic enzymesHANMI PHARM IND CO LTD·Filed 2017·Granted Feb 16, 2021·8 cites·25 claims
- 0793US10894089B2Long-acting insulin or insulin analogue conjugateHANMI PHARM IND CO LTD·Filed 2016·Granted Jan 19, 2021·18 cites·15 claims
- 0893US10400020B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Sep 3, 2019·10 cites·24 claims
- 0992US11667688B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2022·Granted Jun 6, 2023·1 cites·18 claims
- 1092US9522946B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2015·Granted Dec 20, 2016·11 cites·5 claims
- 1191US8029789B2Method for the mass production of immunoglobulin constant regionHANMI HOLDINGS CO LTD·Filed 2004·Granted Oct 4, 2011·25 cites·12 claims
- 1290US11332508B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted May 17, 2022·2 cites·34 claims
- 1390US9394546B2Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Jul 19, 2016·8 cites·13 claims
- 1490US8476230B2Insulinotropic complex using an immunoglobulin fragmentSONG DAE HAE·Filed 2008·Granted Jul 2, 2013·18 cites·20 claims
- 1589US9527898B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameJUNG SUNG YOUB·Filed 2012·Granted Dec 27, 2016·10 cites·17 claims
- 1688US10696725B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2016·Granted Jun 30, 2020·3 cites·27 claims
- 1788US9901621B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2016·Granted Feb 27, 2018·5 cites·15 claims
- 1888US9765131B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2016·Granted Sep 19, 2017·5 cites·7 claims
- 1987US9421244B2Long-acting interferon beta formulation comprising an immunoglobulin fragmentKIM DAE JIN·Filed 2011·Granted Aug 23, 2016·12 cites·20 claims
- 2087US7968316B2Method for the mass production of immunoglobulin Fc region deleted initial methionine residuesHANMI HOLDINGS CO LTD·Filed 2006·Granted Jun 28, 2011·9 cites·15 claims
- 2186US10981967B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted Apr 20, 2021·3 cites·41 claims
- 2286US9750820B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2014·Granted Sep 5, 2017·4 cites·4 claims
- 2386US9072794B2Long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesityWOO YOUNG EUN·Filed 2011·Granted Jul 7, 2015·6 cites·42 claims
- 2485US11261227B2Glucagon derivative and a composition comprising a long acting conjugate of the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Mar 1, 2022·1 cites·9 claims
- 2585US9422349B2N-terminal modified exendin-4JUNG SUNG YOUB·Filed 2008·Granted Aug 23, 2016·8 cites·8 claims
- 2684US10660940B2Preparation method for high-yield production of physiologically active polypeptide conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted May 26, 2020·4 cites·28 claims
- 2784US10550168B2Composition for treating diabetes or diabesity comprising oxyntomodulin analogHANMI PHARM IND CO LTD·Filed 2018·Granted Feb 4, 2020·3 cites·10 claims
- 2882US10493132B2Composition for treating hyperlipidemia comprising oxyntomodulin derivativeHANMI PHARM IND CO LTD·Filed 2017·Granted Dec 3, 2019·2 cites·6 claims
- 2982US10046061B2Site-specific insulin conjugateHANMI PHARM IND CO LTD·Filed 2014·Granted Aug 14, 2018·6 cites·30 claims
- 3082US9789202B2Method for treating cancer using an interferon alpha conjugateJUNG SUNG YOUB·Filed 2012·Granted Oct 17, 2017·7 cites·17 claims
- 3182US7718399B2Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragmentHANMI PHARM IND CO LTD·Filed 2004·Granted May 18, 2010·6 cites·19 claims
- 3281US9597378B2Blood coagulation factor VII and VIIa derivatives, conjugates and complexes comprising the same, and use thereofHANMI SCIENCE CO LTD·Filed 2012·Granted Mar 21, 2017·3 cites·27 claims
- 3380US10435459B2Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver diseaseHANMI PHARM IND CO LTD·Filed 2019·Granted Oct 8, 2019·2 cites·13 claims
- 3480US10363320B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofHANMI SCIENCE CO LTD·Filed 2017·Granted Jul 30, 2019·1 cites·20 claims
- 3580US7704709B2Modified human granulocyte-colony stimulating factor and process for producing sameHANMI PHARM IND CO LTD·Filed 2007·Granted Apr 27, 2010·2 cites·28 claims
- 3680US2022213164A1Triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 3779US10159715B2Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugateHANMI PHARM IND CO LTD·Filed 2015·Granted Dec 25, 2018·3 cites·21 claims
- 3878US12018060B2Glucagon derivativesHANMI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 25, 2024·0 cites·10 claims
- 3978US10487128B2Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Nov 26, 2019·2 cites·13 claims
- 4077US9504757B2Site-specific GLP-2 conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2012·Granted Nov 29, 2016·4 cites·16 claims
- 4176US11058776B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2019·Granted Jul 13, 2021·0 cites·5 claims
- 4276US10973881B2IgG4 Fc fragment comprising modified hinge regionHANMI PHARM IND CO LTD·Filed 2014·Granted Apr 13, 2021·1 cites·12 claims
- 4376US9663565B2Insulinotropic peptide derivative with modified N-terminal chargeHANMI PHARM IND CO LTD·Filed 2014·Granted May 30, 2017·2 cites·13 claims
- 4476US8846874B2IgG Fc fragment for a drug carrier and method for the preparation thereofJUNG SUNG YOUB·Filed 2004·Granted Sep 30, 2014·4 cites·4 claims
- 4576US8822650B2Method for the mass production of immunoglobulin constant regionJUNG SUNG YOUB·Filed 2011·Granted Sep 2, 2014·1 cites·10 claims
- 4676US2023090790A1Long-acting conjugates of glp-2 derivativesHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 4775US11872283B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofHANMI SCIENCE CO LTD·Filed 2019·Granted Jan 16, 2024·0 cites·20 claims
- 4875US10253082B2Long-acting insulin and use thereofHANMI PHARM IND CO LTD·Filed 2015·Granted Apr 9, 2019·2 cites·18 claims
- 4975US6605697B1Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous proteinHANMI PHARM IND CO LTD·Filed 1999·Granted Aug 12, 2003·41 cites·4 claims
- 5075US2021188937A1Long-acting conjugate of triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sung Youb Jung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →